NJ State Employees Deferred Compensation Plan’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,000
| Closed | -$230K | – | 476 |
|
|
2024
Q2 | $230K | Hold |
6,000
| – | – | 0.03% | 403 |
|
|
2024
Q1 | $353K | Hold |
6,000
| – | – | 0.04% | 347 |
|
|
2023
Q4 | $359K | Hold |
6,000
| – | – | 0.05% | 349 |
|
|
2023
Q3 | $228K | Hold |
6,000
| – | – | 0.03% | 397 |
|
|
2023
Q2 | $547K | Hold |
6,000
| – | – | 0.08% | 258 |
|
|
2023
Q1 | $396K | Hold |
6,000
| – | – | 0.06% | 327 |
|
|
2022
Q4 | $310K | Buy |
+6,000
| New | +$310K | 0.05% | 355 |
|